• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

Role of platelet rich plasma in patients with periarthritis shoulder

    Dr. Rahul, Dr. Devendrappa H, Dr. Raghavendra, Dr. Yugandhar S

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 2404-2414

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: Pain and decreased ROM is a common presenting condition to orthopaedic outpatient department. Primary Frozen shoulder is estimated to affect 3 to 5% of the general population since PRP is an autologous biologic material, it involves a minimum risk of Immune reactions and transmission of infectious and contagious disease. With this we need assess the efficacy of PRP Shoulder.
Aim and Objective: To assess the efficacy of Platelet Rich plasma in periarthritis shoulder.
Methods: This study included 50 patients diagnosed with periarthritis shoulder and were recruited from the outpatient department of orthopaedics, VIMS, Bellary from the period between November 2018 -2020. The study included both sexes. All patients were injected intraarticularly with PRP. They were evaluated by visual Analogue scale (VAS) for pain and a shortened version of disabilities of arm, shoulder and hand using DASH score for function.
Results: Descriptive and inferential statistical analysis has been carried out in the present study Descriptive and inferential statistical analysis has been carried out in the present study using Student ‘t’ test (two tailed, dependent & independent) and Fisher test. The improvement in VAS score and DASH scores at 3rd, 6th and 12th week follow up in patients who received PRP injections was statistically more significant compared to scores at the time of admission as inferred by p value of <0.05. Using Student ‘t’ test (two tailed, dependent & independent) and Fisher test. The improvement in VAS score and DASH scores at 3rd, 6th and 12th week follow up in patients who received PRP injections was statistically more significant compared to scores at the time of admission as inferred by p value of <0.05.
Interpretation & Conclusion: Our study concludes that the efficacy of single injection of platelet rich plasma to relieve the pain of Periarthritis shoulder is effective less-invasive lines of treatment over a short term follow up period. However more studies are required to evaluate the efficacy of PRP over long term with multi centric study & comparison with the current available treatment options.
Keywords:
    platelet rich plasma Visual Analogue Scale periarthritis of shoulder dash score intraarticular injection
  • PDF (960 K)
  • XML
(2022). Role of platelet rich plasma in patients with periarthritis shoulder. European Journal of Molecular & Clinical Medicine, 9(2), 2404-2414.
Dr. Rahul, Dr. Devendrappa H, Dr. Raghavendra, Dr. Yugandhar S. "Role of platelet rich plasma in patients with periarthritis shoulder". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 2404-2414.
(2022). 'Role of platelet rich plasma in patients with periarthritis shoulder', European Journal of Molecular & Clinical Medicine, 9(2), pp. 2404-2414.
Role of platelet rich plasma in patients with periarthritis shoulder. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 2404-2414.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 35
  • PDF Download: 77
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus